BAKER & HOSTETLER LLP

Lobbying for FERRING PHARMACEUTICALS, INC. · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 21, 2025

Lobbying activity 1

Health Issues

Regulatory and reimbursement policy issues related to federal healthcare programs associated with gene therapy, IVF therapy and oncology treatments.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.